Omega-3 Dietary Intervention May Prevent Functional Losses of The Sight

Share Article

Current investigation in age-related and progressive decline in retina function points to dietary supplementation of Omega-3, as an effective and broad intervention. In particular, a new study relating to dietary supplementation of DHA Omega-3 fatty acids has resulted in recommendations regarding the Omega-3 and preserved retina function as well as deterring the age-related retina functional losses.

A new study by the Department of Ophthalmology, University of Alberta, Edmonton, Alberta, Canada, suggests that supplementation of Omega-3 fatty acids has resulted in a protective application against a particular toxin, commonly associated with age-related retina functional losses. Nutri-Med Logic Corp, agreeing with study, adds that while dietary intervention of Omega-3 may improve age-related retina dysfunction and some retina degenerative diseases, prophylactic supplementation of Omega-3 would also reduce the risk of developing such dysfunction or diseases, in the first place.

The study by the University of Alberta suggests that DHA Omega-3 dietary supplementation resulted in its increased retina levels for the 1-3 months, 1-6 months trials and while the 1-3 months intervention had no effects, in the 1-6 months intervention the retinal pigment epithelial cells (cell layer just outside the neurosensory retina) function was preserved and the 6-12 months trail led to maintained outer and inner retina function.

The University of Alberta study was conducted on accumulation of a constituent (A2E) of the toxin Lipofuscin, also referred to as the aging pigment and "a wear and tear indicator" for nerve cells and retina ganglion cells. Lipofuscin has been and remains a focus of aging and stress research and there is sufficient evidence to reasonably infer that Lipofuscin can also be used as a marker of oxidative stress and aging, in general. Adv Exp Med Biol. 1989;266:17-26; Discussions 27-9.

Since retina has the highest concentration of DHA Omega-3 fatty acids, many studies such as the University of Alberta study have sought to evaluate if its dietary intervention could improve or delay the onset and/or the progression of retina diseases.

It is a known fact that DHA Omega-3 fatty acids exclusively activate the signaling pathways that can promote cell survival during their early development and protects them, later, from premature death. J. Neurochem. Vol. 98, P. 1507 - Sept. 2006.

Additionally, DHA Omega-3 fatty acids are also the precursor to Docosanoids, which produce neuroprotectin D1, inhibiting premature apoptosis (cell death) and oxidative-stress-mediated pro-inflammatory gene induction. Trends in Neuroscience. 2006 May;29(5):263-71.

Moreover, according to University of Maryland Medical Center, in a study of more than 3,000 people over the age of 49, those who consumed more fish (richest source of Omeg-3) were less likely to have Age-Related Maculate Degeneration (onset) than those who ate fewer fish.
University of Maryland Medical Center further states that other studies show that eating fatty fish reduces the risk of Age-Related Maculate Degeneration "AMD" in half and consuming DHA and EPA fatty acids may even reduce the risk of developing AMD.

Last but not least, according to the Department of Opthalmology, Ottawa Hospital Eye Institute, University of Ottawa, Ontario, Canada, their meta-analysis of eligible studies between 1995 and 2004 indicates trends in improvement of some retinitis pigmentosa outcomes with omega-3 fatty acids in higher quality studies. Can. J. Ophthalmol. 2006 Aug;41(4):481-90.

In conclusion, Nutri-Med Logic Corp, agreeing with this news study, adds that while dietary intervention of Omega-3 has resulted in notable therapeutic values for the age-related retina dysfunction or retina diseases, but the results are associated with the proper duration of its supplementation. Nutri-Med Logic Corp also adds that prophylactic supplementation of Omega-3, both DHA and EPA fatty acids, have been also associated with delaying or deterring the onset of such retina age-related dysfunction and diseases.

Nutri-Med Logic Corp is the producer of the Natural, Balanced, Deodorized, Concentrated & Pharmaceutical Grade Omega-3.

Nutri-Med Logic Corp is also a producer of dietary supplements such as a Pharmaceutical Grade R-Alpha Lipoic Acid, a potent anti-oxidant and the dietary supplement of choice for the Diabetics, in Germany for decades;

Producer of PolyEnylPhosphatidylCholine (PPC 425mg), an extract of soy, a pure and effective dietary source of choline and the recommended dietary supplement for those with Fatty Liver and Alcoholic Liver Disease, in Europe for decades.

Nutri-Med Logic Corp invites you to visit its News Archives and Review its News Releases on other potential benefits of Omega-3 and What is Omega-3 Good For.

Nutri-Med Logic's products are Formulated Based on Nutritional Logic, made from the highest quality raw materials that are manufactured in pharmaceutical facilities, encapsulated in pharmaceutical facilities and packaged in pharmaceutical facilities.

It must be noted that the studies, sources or statements above have not been evaluated by The FDA and, thus, one should not relate the cause of any diseases, stated herein, to lack of the dietary supplements, stated herein, nor equate their supplementation to prevention, treatment or cure.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

H.R. Zadeh
Visit website